Drug intelligence / Profile preview

JOYFINAC GEL

Development stage
Unknown
Lead developer
JoY Pharma
Modality
Small Molecules
Administration
Topical
01

Overview

JOYFINAC GEL is a topical branded generic medication marketed by JoY Pharma, a pharmaceutical company based in Bengaluru, India. It is a small molecule formulation designed for the localized treatment of pain and inflammation. The gel typically contains a combination of diclofenac diethylamine, methyl salicylate, menthol, and linseed oil. Diclofenac, the primary active ingredient, is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits the cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of pro-inflammatory prostaglandins. Methyl salicylate and menthol act as counter-irritants to provide a cooling sensation and further alleviate pain, while linseed oil contributes additional anti-inflammatory properties. JOYFINAC GEL is indicated for the relief of symptoms associated with musculoskeletal disorders such as arthritis, backache, sprains, and strains.

Brand names
JOYFINAC GEL
Other names
JOYFINAC-GEL
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on JOYFINAC GEL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JOYFINAC GEL.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call